81.
Mortality and Other Important Diabetes-Related Outcomes With Insulin vs Other Antihyperglycemic Therapies in Type 2 Diabetes
by Currie, Craig J
The journal of clinical endocrinology and metabolism, 2013, Vol.98 (2), p.668-677
82.
A model to estimate the lifetime health outcomes of patients with Type 2 diabetes: the United kingdom Prospective Diabetes Study (UKPDS) Outcomes Model (UKPDS no. 68)
by CLARKE, P. M
Diabetologia, 2004, Vol.47 (10), p.1747-1759
83.
The cardiovascular safety trials of DPP-4 inhibitors, GLP-1 agonists, and SGLT2 inhibitors
by Secrest, Matthew H
Trends in cardiovascular medicine, 2017, Vol.27 (3), p.194-202
84.
85.
Metformin treatment is associated with a low risk of mortality in diabetic patients with heart failure: a retrospective nationwide cohort study
by Andersson, C
Diabetologia, 2010, Vol.53 (12), p.2546-2553
86.
Targeted multiple biomarker approach in predicting cardiovascular events in patients with diabetes
by Resl, M
Heart (British Cardiac Society), 2016, Vol.102 (24), p.1963-1968
87.
Toe–brachial index as a predictor of cardiovascular disease and all-cause mortality in people with type 2 diabetes and microalbuminuria
by Zobel, Emilie H
Diabetologia, 2017, Vol.60 (10), p.1883-1891
88.
ANGPTL2 is associated with an increased risk of cardiovascular events and death in diabetic patients
by Gellen, Barnabas
Diabetologia, 2016, Vol.59 (11), p.2321-2330
89.
Cardiovascular events and all-cause mortality with insulin versus glucagon-like peptide-1 analogue in type 2 diabetes
by Anyanwagu, Uchenna
Heart (British Cardiac Society), 2016, Vol.102 (19), p.1581-1587
90.
Geographic variation in Medicare spending and mortality for diabetic patients with foot ulcers and amputations
by Sargen, Michael R
Journal of diabetes and its complications, 2013, Vol.27 (2), p.128-133
91.
Associations of type 2 diabetes and diabetes treatment with breast cancer risk and mortality: a population-based cohort study among British women
by Redaniel, Maria Theresa M
Cancer causes & control, 2012, Vol.23 (11), p.1785-1795
92.
Markers of inflammation and endothelial dysfunction are associated with incident cardiovascular disease, all-cause mortality, and progression of coronary calcification in type 2 di...
by von Scholten, Bernt Johan
Journal of diabetes and its complications, 2016, Vol.30 (2), p.248-255
93.
Psychological distress, cardiovascular complications and mortality among people with screen-detected type 2 diabetes: follow-up of the ADDITION-Denmark trial
by Dalsgaard, Else-Marie
Diabetologia, 2014, Vol.57 (4), p.710-717
94.
Advanced Glycation End Products, Measured as Skin Autofluorescence and Diabetes Complications: A Systematic Review
by Bos, Dieuwke C.
Diabetes technology & therapeutics, 2011, Vol.13 (7), p.773-779
95.
Migrant mortality from diabetes mellitus across Europe: the importance of socio-economic change
by Vandenheede, Hadewijch
European journal of epidemiology, 2012, Vol.27 (2), p.109-117
96.
Phosphodiesterase type-5 inhibitor use in type 2 diabetes is associated with a reduction in all-cause mortality
by Anderson, Simon G
Heart (British Cardiac Society), 2016, Vol.102 (21), p.1750-1756
97.
Association between HbA1c variability and mortality in patients with type 2 diabetes
by Takao, Toshiko
Journal of diabetes and its complications, 2014, Vol.28 (4), p.494-499
98.
Impact of empagliflozin in patients with diabetes and heart failure
by Pham, David, MD
Trends in cardiovascular medicine, 2016, Vol.27 (2), p.144-151
99.
The frequency and impact of hypoglycemia among hospitalized patients with diabetes: A population-based study
by Gómez-Huelgas, Ricardo
Journal of diabetes and its complications, 2015, Vol.29 (8), p.1050-1055
100.
Insulin-treated diabetes is associated with a marked increase in mortality in patients with advanced heart failure
by Smooke, Stephanie
The American heart journal, 2005, Vol.149 (1), p.168-174
